Campylobacter jejuni and Hemolytic-Uremic Syndrome
Campylobacter jejuni and Hemolytic-Uremic Syndrome
复制标题
空肠弯曲菌与溶血性尿毒症综合征
作者:
M. Sillero;J. Almirall
Accessible online at: http://BioMedNet.com/karger Dear Sir, The hemolytic-uremic syndrome (HUS) is an infrequent illness characterized by microangiopathic anemia, thrombocytopenic purpura and acute oliguric renal failure. It is a disorder usually encountered in young children. A number of conditions can be associated with HUS, especially infectious diseases. The most frequently described association has been in children infected by the Escherichia coli 0157:H7-producing Shigalike verotoxin. Other less frequently associated infections have been described with Streptococcus pneumoniae, Shigella, Salmonella, Yersinia and several viruses. Infrequently, Campylobacter has been implicated in the development of HUS. In the Medline revision of the last 17 years, only 6 references relate Campylobacter spp. and HUS in adults [1–6]. We describe a new case of HUS that developed after Campylobacter jejuni enteritis in an adult patient. A 76-year-old patient with a simple chronic bronchitis secondary to smoking habit (15 cigarettes/day) was admitted because of oliguria and hematemsesis. Four weeks earlier he had had an acute gastroenteritic episode, with abundant diarrhea and vomiting. C. jejuni was isolated in the stool culture, no coinfection with other pathogens was detected. The evolution was initially favorable with only dietetic measures, but several days later he complained of progressive icterus, general worsening, and progressive oliguria. After further hematemesis, he decided to consult the hospital. At admission he appeared in bad general condition, blood pressure was 14/8 mm Hg, temperature 37 °C. Icterus was evident and a generalized purpura was detected especially in the distal part of the legs. No other remarkable alterations were noted at physical examination. The biochemical and hematological examinations disclosed: normal white blood cell count and formula, hemolytic anemia with 2.7 ! 106 red blood cells, hemoglobin 7.5 mg/dl, abundant peripheral schistocytes, depressed haptoglobin levels (! 5 mg/dl) and thrombopenia of 30,000 elements. Other tests disclosed: GOT 287, GPT 147, LDH 7,135, total bilirubin 5.5 mg/dl (indirect bilirubin 3 mg/dl), urea 270 mg/dl, creatinine 6.6 mg/dl, with normal ionogram. Serological values for hepatitis B, C and HIV were negative; further, immunological tests (cryoglobulins, ANA, ANCA, complement, antiglomerular basement membrane) were normal or negative. Abdominal echography and radiological examinations also were normal. The patient remained severely oliguric after several hours of admission, in spite of the diuretic treatment, with progressive worsening of the kidney function. The diagnosis of HUS was established and we started treatment with fresh-frozen plasma 1,000 ml/ day, dipyridamole 100 mg/8 h, methylprednisolone 80 mg/day intravenously and hemodialysis. After 8 days his overall condition started to improve (table 1); he was discharged after 3 weeks in good general condition. After 6 months he was completely asymptomatic with normal analytical tests. In the last control, 12 months later he was still well. HUS is an infrequent illness, with an approximate incidence in children of 1–2.5 cases/105; in adults the incidence is 1/106 Table 1. Clinical data
DOI:
10.1056/nejm199608293350905
发表时间:
1996
期刊:
The New England journal of medicine.
影响因子:
--
作者:
Tarr,PI;Fouser,LS;Stapleton,AE;Wilson,RA;Kim,HH;VaryJr,JC;Clausen,CR
通讯作者:
Clausen,CR
影响因子:
158.5
作者:
BELL, WR;BRAINE, HG;KICKLER, TS
通讯作者:
KICKLER, TS